Investor Overview

Our Investor Information

Company Overview

Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Annual Report
Press Releases
February 22, 2024
Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan
February 22, 2024
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
Upcoming Events
March 5, 2024 at 2:50 PM EST
TD Cowen 44th Annual Health Care Conference
Investor FAQs
More FAQs are coming soon.

Founded

Delaware, November 2008

Headquarters

222 Berkeley Street, 12th Floor
Boston, MA 02116

CUSIP number

76243J105

Transfer Agent

Computershare Trust Company, Inc.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1-800-962-4284
International Phone: + 1-781-575-3120